NASDAQ · Drug Manufacturers - Specialty & Generic
Tilray Inc (TLRY)
$2.53
-4.17%
18
Oversold
Moving averages
SMA 200$5.92-57.26%
Company profile
Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$496.57M
P/E ratioNone
EPS$-1.41
Beta1.917
Dividend yield0.00%
52-week high$18.40
52-week low$3.25
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 45
CGC
Canopy Growth Corporation
RSI 25
BFRI
Biofrontera Inc
RSI 42
LNTH
Lantheus Holdings Inc
RSI 56
ACB
Aurora Cannabis Inc
RSI 50
ORGO
Organogenesis Holdings Inc - Class A
RSI 16
BCRX
Biocryst Pharmaceuticals Inc
RSI 55
INM
InMed Pharmaceuticals Inc
RSI 71
RSI alerts for TLRY
An email when TLRY closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:09 PM EDT